Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology
Authors:
- Deh-Ming ChangDCDeh-Ming Chang
- Tsung-Chih ChenTCTsung-Chih Chen
- Chia-Chung LeeCLChia-Chung Lee
- Hsi-Hsien HsiehHHHsi-Hsien Hsieh
- Fong-Chun HuangFHFong-Chun Huang
- Kuo-Feng HuangKHKuo-Feng Huang
- Jih-Hwa GuhJGJih-Hwa Guh
- Jing-Jer LinJLJing-Jer Lin
- Hsu-Shan HuangHHHsu-Shan Huang
- 1 February 2013
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 60, 29-41
Abstract
No abstract availableKeywords
Funding Information
- National Science Council (NSC 100-2113-M-016, 101-2113-M-016, 100-2311-B-010-001, 98-2113-M-016-001)
- National Health Research Institutes (NHRI EX100-10050SI)
This publication has 32 references indexed in Scilit:
- Anthracyclines disrupt telomere maintenance by telomerase through inducing PinX1 ubiquitination and degradationOncogene, 2011
- Human telomeric G‐quadruplex: The current status of telomeric G‐quadruplexes as therapeutic targets in human cancerThe FEBS Journal, 2010
- Targeting telomeres and telomeraseBiochimie, 2008
- The nature of telomere fusion and a definition of the critical telomere length in human cellsGenes & Development, 2007
- Beginning to Understand the End of the ChromosomeCell, 2004
- Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factorOncogene, 2003
- Telomerase in the human organismOncogene, 2002
- Recent developments in the field of antitumour anthracyclinesEuropean Journal of Medicinal Chemistry, 2001
- Mammalian telomeres and telomeraseCurrent Opinion in Cell Biology, 2000
- Human telomeres contain at least three types of G–rich repeat distributed non-randomlyNucleic Acids Research, 1989